Astra drug wins EU approval for depression use
Pharmaceutical company AstraZeneca PLC says its schizophrenia drug Seroquel XR has been recommended by European regulators as an add-on treatment for depression.
Read this article:
Astra drug wins EU approval for depression use
Related posts: